The company will compete with a device Boston Scientific acquired for $850 million.

Marlborough medical technology firm Boston Scientific ... currents to interrupt pain signals traveling to the brain, opening the door to effective pain management without the use of opioids.

But when Eddy was recruited to join medical-device maker Boston Scientific in 2013, she “had a vision that we could transform ...

Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market, Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Type of Neurostimulation Device ...

Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market - A Global and Regional Analysis: Focus on Type, Application, End User, and Country - Analysis and Forecast ...

Now, however, that indication includes treatment of chronic pain in the lower back and legs that’s not associated with a past surgery, Boston Scientific announced Tuesday. The expanded FDA nod ...

Boston Scientific Corporation ... BSX is under-leveraged in pain treatment, and I think this is an area that could use some extra management attention to rectify. Lastly, I do have some concerns ...